Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Emotions of PD

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Unmasking the emotions of Parkinson’s

READ MORE
PD and genetics

Resources & Tools

Parkinson’s podcast: Genetics and Parkinson’s disease

Will genetics help us crack the Parkinson's code?

READ MORE
Parkinson's 100 Challenge

Global update

Join the Parkinson’s 100 Challenge – to raise €50,000

Are you ready to take the Parkinson's 100 Challenge?

READ MORE